Pharmacologic profile of BN 50739, a new PAF antagonist and
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 39 (5), 469-480
- https://doi.org/10.1016/0090-6980(90)90031-p
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effects of anti-asthma drugs on PAF-induced death in miceProstaglandins, 1988
- Platelet-Activating Factor Antagonist BN52021 Decreases Accumulation of Free Polyunsaturated Fatty Acid in Mouse Brain During Ischemia and Electroconvulsive ShockJournal of Neurochemistry, 1988
- Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.Journal of Clinical Investigation, 1988
- WEB 2086Drugs of the Future, 1988
- Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.Circulation Research, 1988
- Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.Journal of Clinical Investigation, 1987
- Biological properties of the antagonist SRI 63–441 in the PAF and endotoxin models of hypotension in the rat and dogImmunopharmacology, 1987
- Prostaglandins, Leukotrienes, and Platelet-Activating Factor in ShockAnnual Review of Pharmacology and Toxicology, 1987
- Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988European Journal of Pharmacology, 1986
- Methods for the Preparation of Washed Platelet SuspensionsPublished by Springer Nature ,1972